Maria Valdenebro Recio

Mrs. Maria Valdenebro Recio


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MRMaria Valdenebro Recio
Maria Valdenebro Recio
JPJosé Portoles
José Portoles
MSMaría Luisa Serrano Salazar
María Luisa Serrano Salazar
ASAna Muñoz Sánchez
Ana Muñoz Sánchez
IAInes Alameda-Aguado
Ines Alameda-Aguado
PLPaula Lopez-Sanchez
Paula Lopez-Sanchez
Introduction: Acute kidney injury (AKI) significantly disrupts vital renal functions and is a common and serious condition in intensive care units (ICUs). AKI leads to extended hospital stays, increases mortality rates, and often necessitates nephrology consultations. Continuous renal replacement therapy (CRRT) plays a central role in managing AKI, requiring a multidisciplinary approach involving nephrologists, intensivists, and anesthesiologists. This study examines the clinical profile and progression of AKI in ICU patients requiring CRRT, with a focus on CRRT indications and modalities. Materials and Methods: We conducted a single-center retrospective observational study on ICU patients with AKI requiring CRRT from January to December 2019. AKI diagnosis followed the RIFLE criteria, and patients who received CRRT for less than 36 h were excluded. Data collected included demographics, hemodynamic parameters, and renal function parameters, with follow-ups at 1 week, 1 month, 6 months, and 12 months. Statistical analyses evaluated outcomes and transitions between CRRT and other renal replacement therapies. Results: Among 123 evaluated patients, 95 met inclusion criteria. Fifteen patients received CRRT for less than 36 h, with an early mortality rate of 80%. The final cohort comprised 80 patients who underwent CRRT for over 36 h, with a mean age of 65.3 years (SD = 13.6) and a Charlson index of 6.4. Patients were categorized based on primary diagnosis into heart failure, cardiac surgery, sepsis, other surgeries, and miscellanea groups. Mortality rates were highest in the heart failure and miscellanea groups. Significant variability was observed in therapy transitions and long-term outcomes. Continuous venovenous hemodiafiltration (CVVHDF) was the most frequently used CRRT modality. Conclusions: This study highlights the variability in CRRT practices and the poor prognosis for critically ill patients with AKI requiring CRRT. Timely nephrology consultation and tailored treatment plans may improve patient outcomes and optimize CRRT utilization. Future research should focus on refining CRRT protocols and exploring preventive strategies for AKI.

1 August 2025 in Journal Of Nephrology
Verified
Journal Article
Open access
PDF file
AMAna Muñoz-Sánchez
Ana Muñoz-Sánchez
LRLEYRE MARTIN RODRIGUEZ
LEYRE MARTIN RODRIGUEZ
PLPaula Lopez-Sanchez
Paula Lopez-Sanchez
MRMaria Valdenebro Recio
Maria Valdenebro Recio
MSMaria Luisa Serrano-Salazar
Maria Luisa Serrano-Salazar
JPJosé Portoles
José Portoles
Background: Acute Kidney Injury (AKI) is frequent and is associated with adverse outcomes. Aims: To analyze the impact of community-acquired and hospital-acquired AKI on in-hospital and five-year post-discharge kidney replacement therapy (KRT) requirement in the pre-COVID era. Methods: We linked the regional health system database of 419,851 admissions to the regional KRT registry. We grouped all admissions into 3 categories: community-acquired AKI, where AKI was the primary diagnosis, and hospital-acquired AKI, where AKI was an additional diagnosis alongside another primary condition. Admissions without this code were grouped into a third category (no AKI). We excluded patients aged under 18 years old, those with previous KRT, and pregnant women. The study was approved by the ethics committee. Patients were followed up for five years after discharge. Results: Community-acquired AKI accounted for 0.6% of all admissions, associated prolonged average hospital stays, and increased mortality rates. In-hospital KRT administration was required in 3.1% of cases, and after a mean follow-up time of 459 days, 7.2% of these patients began chronic KRT. Hospital-acquired AKI represented 6.1% of all admissions and was associated with the highest mortality rate (22.9% vs 14.4% in the community-acquired AKI group) and the longest average hospital stay (12.6 days vs 7.1 in the no AKI group). Only 0.5% of hospital-acquired AKI cases required KRT during the AKI episode, while 2% of these patients initiated chronic KRT after a mean follow-up time of 594 days. Conclusions: AKI continues to be a frequent problem in clinical practice, negatively influencing patient morbidity and mortality, and increasing the risk of starting KRT in the medium-long term. Graphical

1 November 2015 in Nefrología
Verified
Journal Article
Open access
MRMaria Valdenebro Recio
Maria Valdenebro Recio
MVMaría Marques Vidas
María Marques Vidas
EREsther Rubio
Esther Rubio
EPEdwin Palomino
Edwin Palomino
EGEstefanya García
Estefanya García
JPJosé Portoles
José Portoles

25 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MSMaria Luisa Serrano Salazar
Maria Luisa Serrano Salazar
CACarlos Almonacid
Carlos Almonacid
MVMaría Marques Vidas
María Marques Vidas
PLPaula Lopez-Sanchez
Paula Lopez-Sanchez
BSBeatriz Sánchez Sobrino
Beatriz Sánchez Sobrino
JPJosé Portoles
José Portoles
Objectives: Chronic kidney disease (CKD) among lung transplant (LTx) recipients has increased in recent decades. However, there is insufficient evidence regarding clinical outcomes, and current guidelines lack specific recommendations for its management. Methods: This single-center retrospective study included all patients who underwent LTx and were subsequently referred to a dedicated nephrology outpatient clinic. Major adverse renal events were defined as a composite event. Results: Eighty LTx recipients with underlying lung disease etiology such as cystic fibrosis, chronic obstructive pulmonary disease, or interstitial lung disease were included. The mean time from LTx to first nephrologist evaluation was 4.7 years with an eGFR of 31.7 mL/min/1.73 m2. LTx recipients experienced a 48% reduction in eGFR within the first few months after LTx. Rapid progressors require renal replacement therapy earlier than the slow progressors. Patients requiring dialysis had higher all-cause mortality compared to those who did not require dialysis. Conclusions: Early post-LTx functional impairment appears to be the most significant predictor for CKD progression and the eventual need for RRT. Although CNI toxicity is the most common cause of CKD, early nephrology evaluation can uncover other causes and promote early renoprotective measures. For this patient population, specific guidelines addressing CKD after LTx and a multidisciplinary approach are essential.

1 November 2015 in Nefrología (English Edition)
Verified
Journal Article
Open access
MRMaria Valdenebro Recio
Maria Valdenebro Recio
MMMaría Marques
María Marques
EREsther Rubio
Esther Rubio
EPEdwin Palomino
Edwin Palomino
EGEstefanya García
Estefanya García
JPJosé Portolés
José Portolés